By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Rosetta Genomics today announced a deal with the University of California, Davis aimed at predicting patient response to neoadjuvant chemotherapy for bladder cancer.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: measles virus nucleocapsid structure, and more.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
Nature has retracted a 2002 epigenetics paper for image manipulation.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.